Treatments for Squamous Cell Cancer

Treatments for Squamous Cell Cancer

Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an...

Full description

Saved in:
Bibliographic Details
Sonstige:
Darido, Charbel
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (168 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993560440604498
ctrlnum (CKB)5680000000080786
(oapen)https://directory.doabooks.org/handle/20.500.12854/92097
(EXLCZ)995680000000080786
collection bib_alma
record_format marc
spelling Darido, Charbel edt
Treatments for Squamous Cell Cancer
Basel MDPI Books 2022
1 electronic resource (168 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes.
English
Medicine bicssc
Oncology bicssc
oral cancer
tobacco
alcohol
human papilloma virus
targeted sequencing
DNA copy number
TP53
CDKN2A
EGFR
PIK3CA
anal cancer
radiation therapy
chemoradiation
de-escalation of therapy
pain
cathepsin S
protease-activated receptor-2
PAR2
cancer pain
oral squamous cell carcinoma
differentiation
terminal differentiation
oral epithelium
epithelial integrity
epithelial transformation
genetic alterations
therapy response biomarkers
cutaneous squamous cell carcinoma
immunotherapy
anti-PD1
biomarkers
predictive medicine
personalized medicine
cancer
immune system
HNSCC
farnesyl transferase
tipifarnib
combination regimen
oropharynx
neoplasm
squamous cell carcinoma
human papillomavirus
therapeutic management
treatment selection
CSCC
treatment
advances
biology
immunocompromised
immune checkpoint inhibition
3-0365-4757-6
3-0365-4758-4
Darido, Charbel oth
language English
format eBook
author2 Darido, Charbel
author_facet Darido, Charbel
author2_variant c d cd
author2_role Sonstige
title Treatments for Squamous Cell Cancer
spellingShingle Treatments for Squamous Cell Cancer
title_full Treatments for Squamous Cell Cancer
title_fullStr Treatments for Squamous Cell Cancer
title_full_unstemmed Treatments for Squamous Cell Cancer
title_auth Treatments for Squamous Cell Cancer
title_new Treatments for Squamous Cell Cancer
title_sort treatments for squamous cell cancer
publisher MDPI Books
publishDate 2022
physical 1 electronic resource (168 p.)
isbn 3-0365-4757-6
3-0365-4758-4
illustrated Not Illustrated
work_keys_str_mv AT daridocharbel treatmentsforsquamouscellcancer
status_str n
ids_txt_mv (CKB)5680000000080786
(oapen)https://directory.doabooks.org/handle/20.500.12854/92097
(EXLCZ)995680000000080786
carrierType_str_mv cr
is_hierarchy_title Treatments for Squamous Cell Cancer
author2_original_writing_str_mv noLinkedField
_version_ 1796649042618351616
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02943nam-a2200913z--4500</leader><controlfield tag="001">993560440604498</controlfield><controlfield tag="005">20231214133358.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202209s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000080786</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/92097</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000080786</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Darido, Charbel</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatments for Squamous Cell Cancer</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI Books</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (168 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oncology</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oral cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tobacco</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alcohol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human papilloma virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA copy number</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TP53</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CDKN2A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PIK3CA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiation therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemoradiation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">de-escalation of therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cathepsin S</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protease-activated receptor-2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PAR2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oral squamous cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">differentiation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">terminal differentiation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oral epithelium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epithelial integrity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epithelial transformation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic alterations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapy response biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cutaneous squamous cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-PD1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">predictive medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HNSCC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">farnesyl transferase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tipifarnib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">combination regimen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oropharynx</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neoplasm</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">squamous cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human papillomavirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutic management</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment selection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CSCC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">advances</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunocompromised</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoint inhibition</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4757-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4758-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Darido, Charbel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:52:22 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5344131070004498&amp;Force_direct=true</subfield><subfield code="Z">5344131070004498</subfield><subfield code="b">Available</subfield><subfield code="8">5344131070004498</subfield></datafield></record></collection>

Similar Items